Pilar Herrera Selected Research

Pilar Herrera Research Topics

13	Acute Myeloid Leukemia (Acute Myelogenous Leukemia) 05/2023 - 01/2014
4	Neoplasms (Cancer) 01/2022 - 01/2018
3	COVID-19 01/2024 - 10/2020
3	Leukemia 08/2023 - 09/2018
3	Myelodysplastic Syndromes (Myelodysplastic Syndrome) 01/2022 - 12/2010
2	Graft vs Host Disease (Graft-Versus-Host Disease) 01/2022 - 09/2018
2	Multiple Myeloma 01/2022 - 12/2010
2	Infections 10/2021 - 02/2019
2	Residual Neoplasm 01/2019 - 10/2015
1	B-Cell Chronic Lymphocytic Leukemia (Chronic Lymphocytic Leukemia) 01/2024
1	Burkitt Lymphoma (Burkitt's Lymphoma) 08/2023
1	Follicular Lymphoma (Lymphoma, Small Cleaved Cell, Follicular) 11/2022
1	Mantle-Cell Lymphoma (Lymphoma, Mantle Cell) 05/2022
1	Dyspnea (Shortness of Breath) 12/2021
1	Diffuse Large B-Cell Lymphoma (Lymphoma, Large Cell, Diffuse) 01/2021
1	Non-Hodgkin Lymphoma (Lymphosarcoma) 10/2020
1	Hematologic Neoplasms (Hematological Malignancy) 10/2020
1	Bronchiolitis Obliterans Syndrome 02/2019
1	Isochromosomes 12/2010

4	Cytarabine (Cytosar-U)FDA LinkGeneric 05/2021 - 01/2014
2	Cyclophosphamide (Cytoxan)FDA LinkGeneric 01/2022 - 09/2018
2	Azacitidine (5 Azacytidine)FDA Link 05/2021 - 01/2021
2	fludarabineIBA 05/2021 - 01/2021
1	remdesivirIBA 01/2024
1	nirmatrelvir and ritonavir drug combinationIBA 01/2024
1	N-(2-cyanoethylene)urea (BA 1)IBA 01/2024
1	N-methyl-valyl-amiclenomycin (BA 2)IBA 01/2024
1	Tyrosine Kinase InhibitorsIBA 06/2022
1	fms-Like Tyrosine Kinase 3IBA 06/2022
1	Bortezomib (Velcade)FDA Link 01/2022
1	Lenalidomide (CC 5013)FDA Link 01/2022
1	fibrin fragment D (D-dimer)IBA 12/2021
1	Oxygen (Dioxygen)IBA 10/2021
1	venetoclaxIBA 01/2021
1	Monoclonal AntibodiesIBA 10/2020
1	Antineoplastic Agents (Antineoplastics)IBA 10/2020
1	Antiviral Agents (Antivirals)IBA 10/2020
1	Methotrexate (Mexate)FDA LinkGeneric 02/2019
1	GlobulinsIBA 02/2019
1	Cyclosporine (Ciclosporin)FDA LinkGeneric 02/2019
1	Thomsen-Friedenreich antibodiesIBA 02/2019
1	AnthracyclinesIBA 01/2019
1	NucleotidesIBA 01/2019
1	Busulfan (Busulfex)FDA Link 09/2018
1	PanobinostatIBA 10/2015
1	Drug CombinationsIBA 08/2014
1	Clofarabine (Clolar)FDA Link 01/2014

7	Therapeutics 05/2022 - 10/2015
6	Drug Therapy (Chemotherapy) 05/2023 - 01/2014
5	Stem Cell Transplantation 01/2024 - 02/2019
3	Hematopoietic Stem Cell Transplantation 11/2022 - 01/2021
3	Transplantation 01/2022 - 09/2018
2	Homologous Transplantation 01/2022 - 01/2018
1	Drug Tapering 08/2023
1	Radiotherapy 01/2022
1	Critical Care (Surgical Intensive Care) 12/2021
1	Haploidentical Transplantation 09/2018
1	Precision Medicine 08/2014
1	Aftercare (After-Treatment) 12/2010